Yeah I can still see there's too many sellers in the depth to keep people buying. We'll probably end up back to where we were trading on very low volume.
“We are prioritising margin improvement and product innovation over near-term revenue growth for the Subscription division to enable us to build a stronger platform to maximize longer-term growth for this business unit.”
I take this paragraph to mean they aren't overly concerned with the growth of this portion of the business and they would rather use the consistent cash generation to leverage Q&A, or it's just fluff.
I do like the facebook chatbot comment that's encouraging, and also they're still in negotiations for the debt but who knows how long that may take.
Hopefully there's enough volume to churn out who isn't really interested in being here before we get stuck in the slow lane again.
- Forums
- ASX - By Stock
- Ann: Crowd Mobile reports record quarterly result-CM8.AX
Yeah I can still see there's too many sellers in the depth to...
-
- There are more pages in this discussion • 93 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add UNT (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.90M |
Open | High | Low | Value | Volume |
1.3¢ | 1.3¢ | 1.3¢ | $3.822K | 294K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 4378333 | 1.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.4¢ | 2663574 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 4378333 | 0.012 |
10 | 2416776 | 0.011 |
7 | 2373000 | 0.010 |
4 | 1800000 | 0.009 |
2 | 1120000 | 0.008 |
Price($) | Vol. | No. |
---|---|---|
0.014 | 2663574 | 8 |
0.015 | 1196269 | 7 |
0.016 | 660000 | 2 |
0.017 | 1292273 | 6 |
0.018 | 262679 | 2 |
Last trade - 14.13pm 12/07/2024 (20 minute delay) ? |
Featured News
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
UNT (ASX) Chart |